TRIAL MANAGEMENT
Altasciences Has You Covered From Coast To Coast
With your success in mind, we designed an integrated early phase drug development offering with eight locations, to get you from lead candidate selection to clinical proof of concept, and beyond.
Defining And Implementing The Right Oncology Digital Strategy
A panel of oncology experts shares how top life science companies are using a combination of DHTs, ePROs, clinical trial platforms, and more to ease oncology research and drastically reduce timelines.
End-To-End Clinical Data Flow
Explore the interconnected data flow across Veeva Vault EDC, Veeva CDB, Veeva RTSM, and Veeva ePRO to visualize how these products work together seamlessly.
How RWD Reshapes Patient Recruitment Strategies
Discover how real-world data (RWD) is transforming patient recruitment by shifting from traditional site-centered methods to a patient-first approach.
Are Your Clinical Study Meetings Building Momentum, Or Wasting Time?
Transforming passive clinical trial meetings into active catalysts for success, aligning teams and accelerating timelines.
Keeping Your Trials In Motion And Use AI Where It Makes Sense
Explore the "pinball" approach used by the Judi platform that is giving stakeholders a distinct competitive advantage in the clinical trial landscape.
Take A Look Inside The Pharmacodynamic Toolbox
This session explores the flexible selection of pharmacodynamic measures to enhance the pharmacology, safety, and efficacy evaluation of a CNS-active drug in early clinical trials.
Driving Simulation Studies At Altasciences
At Altasciences, we design driving studies to achieve your objectives, leveraging extensive experience across clinical testing of cognitive effects.
Ensuring Completeness, Accuracy, And Consistency From Source To Archive
Discover how proficient TMF handling can proactively address potential pitfalls, fostering a state of preparedness for regulatory evaluations.
Webinar: Reimbursement Methods For Sustainable CGT Business Models
Learn more about the key features of successful innovative pricing and reimbursement models as well as outcomes-based agreements and the ways to advance those strategies for cell and gene therapies.
Why Disclosure As A Service?
Two clinical trial sponsors – one larger pharmaceutical company and one smaller biotech – share with TrialScope what their main reasons were for initially considering Disclosure as a Service. Watch the short video.
The Path Forward, Altasciences' Approach To Project Management
Learn about a unique, integrated program management strategy that can lower your costs and reduce program timelines from lead candidate selection to clinical proof-of-concept by up to 40%.
Clinical Research Without Borders
Explore strategies for navigating global clinical trials with, Afshawn Chakamian of Avidity Biosciences, Dr. Amy Raymond of Worldwide Clinical Trials, Scott Schliebner of Novotech, and Scout’s KimberLee Heidmann.
The Golden Era Of GLP-1 Drugs
As GLP-1 drugs reshape the market, understanding their potential risks, applications, and economic effects is crucial for professionals in the pharmaceutical and healthcare industries.
Digital Physical Activity Measures In Phase 3 Immunology Trials
Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.
Practical Approaches To Faster Study Start-Ups
Learn how teams can leverage organizational, procedural, and technological solutions to recapture valuable days, weeks, and even months in the activation timelines of research sites.
Cognitive, Pharmacodynamic Testing During FIH CNS Trials
A comprehensive review of optimal timing and methodologies for cognitive and pharmacodynamic testing during first-in-human trials on CNS-active compounds.
Solving The Impossible In Glioblastoma With An AI Synthetic Control Arm
This video discusses Medicenna’s MDNA55-05 clinical trial; a single-arm, open-label, multicenter study that offers a promising opportunity to improve outcomes for recurrent glioblastoma.
Patient First Solutions For Oncology
Medable, Inc's new oncology offering is an end-to-end suite that includes an extensive eCOA library, pre-built and validated DCT applications such as Total Consent and Televisit, and protocol design consulting.
CAR-T Cell Therapies: Advancements In Cancer Trials & Treatment
Watch as Managing Editor of Pharmaceutical Technology Jeanne Linke Northrop talks with Tanmay Jain, Sr. Director of Trial Design Solutions within Medidata AI, about the use of CAR-T cell therapies within the oncology space.
Investigator SmartSelect
This advanced recommendation engine identifies protocol-specific investigators in just minutes, dramatically shortening a process that typically takes four to six weeks.
TMF Management In Clinical Trials
Elevate your knowledge of clinical trials and the Trial Master File by exploring three critical topics.
Think U.S.A.: The Operations Behind Your Clinical Trials
Ready to think differently about early-phase clinical development? Check out the spotlight on our U.S. clinical facilities and the incredible teams behind them.
Tackling The EU CTR Compliance Challenge
Maintaining disclosure compliance is tricky enough with ClinicalTrials.gov, but when it comes to EU CTR compliance, the complexity rises to a whole new level. As a sponsor, do you find your organization “guilty” of these common errors?
Clinical Trials And TMF 101 Learning Series: 2nd Session
The “Clinical Trials and TMF 101 Learning Series” kicks off it’s second session with three industry experts, that goes through some of the basics of clinical trials.
Learning About The Sensors In myMedidata
Learn how sensor data and advanced analytics can transform clinical research and enable your study to overcome data challenges, improving patient care.
Optimize Protocols For More Successful Trials
Find out how you can harness the power of AI and world-class data to recommend endpoints and inclusion/exclusion criteria for streamlined protocol design that results in more positive trial outcomes.
Navigating Early Phase CNS-Active Drug Development
Early development of CNS-active drugs requires in-depth clinical expertise. Altasciences’ Dr. Beatrice Setnik, Chief Scientific Officer, examines the strategies to ensure early comprehensive data collection to fulfill regulatory requirements and aid in evaluating th...
At The Crossroads Of Data: eCOA And Sensors Converging For Novel Insights
Leveraging sensors and eCOA addresses increasing clinical trial complexity and ensures a more efficient and effective study design.
What Is The Secret To Ongoing TMF Health?
Delve into specific tactics clinical teams can utilize for establishing immediate and long-lasting improvements to their TMF business processes.